Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing its own internal pipeline. To learn more, visit https://variational.ai.
Location: Canada, British Columbia, Vancouver
Employees: 11-50
Total raised: $5.5M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Flying Fis... | flyingfish... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.02.2025 | Seed | $5.5M | - |
Mentions in press and media 16
| Date | Title | Description |
| 24.03.2026 | Enamine Joins Agora Open Science Trust and Variational AI to Advance Open-Science Discovery of PRMT6 Inhibitors | KYIV, UKRAINE, March 24, 2026 /EINPresswire.com/ -- Enamine, a leading integrated drug discovery contract research organization (CRO) has today announced its participation in an open-science collaboration with Variational AI and the Agora O... |
| 26.02.2025 | Variational AI: $5.5 Million Raised For Small Molecule Drug Discovery | Variational AI (the company behind Enki) – which is an advanced foundation model for small molecule drug discovery – announced the completion of its oversubscribed $5.5 million Seed extension round. Nimbus Synergies led the round, with part... |
| 20.02.2025 | Variational AI: Pioneering the Future of Drug Discovery with Generative AI | In the world of pharmaceuticals, the quest for new drugs is akin to searching for a needle in a haystack. The process is long, tedious, and often fraught with uncertainty. Enter Variational AI, a Vancouver-based company that is reshaping th... |
| 20.02.2025 | Variational AI Raises $5.5M in Seed Extension Funding | Variational AI, a Vancouver, BC, Canada-based developer of a foundation model for small molecule drug discovery, raised $5.5M in Seed extension funding. The round was led by Nimbus Synergies, with participation from Merck Global Health Inno... |
| 20.02.2025 | Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery | New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies VANCOUVER, British Columbia–(BUSINESS WIRE)–February 20, 2025– Variational AI, the company behind Enki™, an advanced foundation model... |
| 25.01.2024 | Variational AI Announces Generative AI Project With Merck | Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules VANCOUVER, British Columbia–(BUSINESS WIRE)–January 25, 2024– Variational AI, developer of the Enki™ generative artificial intelli... |
| 25.01.2024 | Variational AI Announces Generative AI Project With Merck | Merck to evaluate Variational AI’s Enki generative AI platform to design novel and selective small molecules Variational AI, developer of the Enki generative artificial intelligence (AI) platform for pharmaceutical innovation, announced a p... |
| 08.01.2023 | 🏙️ 'Maybe even a unicorn?' | As we kick off 2023, we’re not just revisiting some of the top tech news in Vancouver; we’re also tipping our cap to the growing communities that border both sides of our city. There’s a $5 billion innovation economy in Victoria, as well as... |
| 04.01.2023 | 🏙️ IRL in Vancouver: How AI will change everything | Welcome to 2023. If you’re new here, this is the Wednesday Events Briefing. At least it was. Or, it is — until next week. It’s typically been a weekly email with nothing more than upcoming social activities. But, starting January 11, we’ll ... |
| 03.07.2022 | 😳 $40M in fuel | Morning friends. I spent this long weekend in Coquitlam, and the Canada Day fireworks display at Lafarge Lake was fantastic. It was sooo good that I’ve already put it in my calendar for next year. Now, as to what’s on my agenda for this mon... |
Show more